Healthcare Analysis of the U.S. Cancer Biomarker Testing Market

Targeted Sequencing of Tumor Mutations is on the Horizon

INDUSTRY
Healthcare

RELEASE DATE
29-Jun-2012
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
NB1D-01-00-00-00
SKU
HC02229-NA-MR_07963
Yes
SHARE

Analysis of the U.S. Cancer Biomarker Testing Market
Published on: 29-Jun-2012 | SKU: HC02229-NA-MR_07963

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research service analyzes the U.S. cancer biomarker testing market from 2009 to 2017. Topics include an overview of the market, along with definitions, metrics, drivers, and restraints. Also offered is an evaluation of ongoing technology trends and major market competitors and their corresponding market shares and product offerings. Based on this analysis, revenue forecasts and growth rates are projected for each segment of the market. This study also provides cancer epidemiology trends, voice-of-customer research on oncologists, and the challenges and strategies for cancer biomarker validation.

Research Service

  • Executive Summary
  • Market Overview

Total U.S. Cancer Biomarker Testing Segment

  • Industry Trends
  • External Challenges: Drivers and Restraints
  • Forecasts and Trends
  • Market Share and Competitive Analysis
  • Product Analysis
  • Epidemiology
  • Voice-of-Customer Research
  • Cancer Biomarker Validation Challenges and Strategies

Molecular Cancer Biomarker Testing Segment Breakdown

  • Forecast and Trends

Traditional Cancer Biomarker Testing Segment Breakdown

  • Forecasts and Trends

The Last Word

  • Conclusions and Implications

Appendix

  • Appendix

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This research service analyzes the U.S. cancer biomarker testing market from 2009 to 2017. Topics include an overview of the market, along with definitions, metrics, drivers, and restraints. Also offered is an evaluation of ongoing technology trends and major market competitors and their corresponding market shares and product offerings. Based on this analysis, revenue forecasts and growth rates are projected for each segment of the market. This study also provides cancer epidemiology trends, voice-of-customer research on oncologists, and the challenges and strategies for cancer biomarker validation.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Author Winny Tan
Industries Healthcare
WIP Number NB1D-01-00-00-00
Is Prebook No

Analysis of the U.S. Cancer Biomarker Testing Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02229-NA-MR_07963